Asia-Pacific Measurable/Minimal Residual Disease (MRD) Testing Market Analysis 2023-2033 - Medicare Expansion and Rising Consumer Awareness Driving Growth
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033" report has been added to * ResearchAndMarkets.com's* offering.
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.
The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.
*Key Attributes*
*Report Attribute* *Details*
No. of Pages 64
Forecast Period 2023-2033
Estimated Market Value (USD) in 2023 $0.3 Billion
Forecasted Market Value (USD) by 2033 $1.33 Billion
Compound Annual Growth Rate 16%
Regions Covered Asia-Pacific
*Key Topics Covered*
*Executive Summary*
*1 Markets*
1.1 Market Scope
1.1.1 Key Questions Answered in the Report
1.2 Research Methodology
1.2.1 MRD Testing Market: Research Methodology
1.2.2 Data Sources
1.3 Market Estimation Model
1.3.1 Criteria for Company Profiling
*2 Market Overview*
2.1 MRD Testing Workflow Analysis
2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
2.3 Evolution of MRD Testing
2.4 Market Footprint
2.5 Market Size and Future Growth Potential
*3 Industry Insights*
3.1 Legal and Regulatory Framework of MRD Tests
3.1.1 Asia-Pacific
3.2 Reimbursement Scenario
3.2.1 Asia-Pacific
3.3 Supply Chain Analysis
3.3.1 For Laboratory Developed Tests (LDTs)
3.3.2 For In-Vitro Diagnostics (IVDs)
*4 Minimal Residual Disease Testing Market (by Region), 2022-2033*
4.1 Overview
4.2 Asia-Pacific
4.2.1 Asia-Pacific MRD Testing Market, by End User
4.2.2 Asia-Pacific MRD Testing Market, by Country
*5 Company Profiles*
5.1 Overview
5.2 Sysmex Corporation
5.2.1 Company Overview
5.2.2 Role of Sysmex Corporation in the MRD Testing Market
5.2.3 Financials
5.2.4 Analyst Perspective
For more information about this report visit https://www.researchandmarkets.com/r/in3nmy
*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
*Attachment*
· Asia-Pacific MRD Testing Market
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900